Experiment 813474

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismMaytenus buchananii (CELASTRACEAE)
CitationCHABNER,BA: LEVINE,AS: JOHNSON,BL: YOUNG,RC:. (1978). INITIAL CLINICAL TRIALS OF MAYTANSINE, AN ANTITUMOR PLANT ALKALOID.. 62()
Amount utilized
Compound isolated
DiseasePHASE I CLINICAL TRIAL IN CANCER PATIENTS-PATIENTS DOSED ONCE EVERY THREE WEEKS PROFOUND WEAKNESS,DIARRHEA,NAUSEA,VOMITING PERSISTING FOR 3-14 DAYS AFTER DRUG ADMINISTRATION
Dose amount2.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES